Severe Thrombocytopenia in a Patient with COVID-19

Coronavirus disease 2019 (COVID-19) outbreak is spreading rapidly all over the world, being a major threat to public health. Since clinical feature of COVID-19 has not been fully evaluated yet, empirical antibacterial agents are frequently combined for the treatment of COVID-19 in addition to antivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nham, Eliel, Ko, Jae-Hoon, Jeong, Byeong-Ho, Huh, Kyungmin, Cho, Sun Young, Kang, Cheol-In, Chung, Doo Ryeon, Peck, Kyong Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533212/
https://www.ncbi.nlm.nih.gov/pubmed/32342677
http://dx.doi.org/10.3947/ic.2020.52.3.410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533212/
https://www.ncbi.nlm.nih.gov/pubmed/32342677
http://dx.doi.org/10.3947/ic.2020.52.3.410

Ejemplares similares